Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $265,000 | 149 | 65.3% |
| Consulting Fee | $76,475 | 24 | 18.9% |
| Travel and Lodging | $34,369 | 106 | 8.5% |
| Food and Beverage | $29,714 | 1,099 | 7.3% |
| Education | $144.30 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $172,923 | 292 | $0 (2024) |
| Allergan, Inc. | $127,212 | 207 | $0 (2022) |
| Lilly USA, LLC | $30,756 | 98 | $0 (2024) |
| ABBVIE INC. | $29,790 | 166 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $13,376 | 31 | $0 (2021) |
| Ipsen Innovation | $9,254 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $6,720 | 21 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $5,535 | 111 | $0 (2024) |
| Promius Pharma LLC | $1,786 | 15 | $0 (2019) |
| Novartis Pharma AG | $1,000 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,555 | 91 | ABBVIE INC. ($10,616) |
| 2023 | $4,480 | 150 | ABBVIE INC. ($2,568) |
| 2022 | $3,376 | 133 | Amgen Inc. ($1,073) |
| 2021 | $78,124 | 185 | Allergan, Inc. ($31,103) |
| 2020 | $61,832 | 181 | Allergan, Inc. ($34,410) |
| 2019 | $113,256 | 268 | Amgen Inc. ($77,842) |
| 2018 | $106,979 | 248 | Amgen Inc. ($72,483) |
| 2017 | $26,101 | 125 | Allergan Inc. ($16,893) |
All Payment Transactions
1,381 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: PAIN | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.69 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: PAIN | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: PAIN | ||||||
| 09/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Insomnia | ||||||
| 09/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Musculoskeletal | ||||||
| 09/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 289 | 16,746 | $293,809 | $114,593 |
| 2022 | 8 | 310 | 20,452 | $352,032 | $139,829 |
| 2021 | 8 | 304 | 20,260 | $338,921 | $136,082 |
| 2020 | 9 | 384 | 23,312 | $333,239 | $155,756 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 16,100 | $132,825 | $79,796 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 165 | $58,004 | $11,297 | 19.5% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 95 | 311 | $38,519 | $7,598 | 19.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 29 | 67 | $28,140 | $6,364 | 22.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 14 | 43 | $16,027 | $5,377 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 23 | $11,316 | $2,263 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 37 | $8,978 | $1,899 | 21.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 31 | 19,700 | $162,525 | $96,543 | 59.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 228 | $80,151 | $17,234 | 21.5% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 95 | 290 | $35,992 | $7,554 | 21.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 28 | 70 | $29,400 | $6,825 | 23.2% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 13 | 49 | $18,263 | $5,566 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 40 | $19,680 | $4,754 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 15 | $3,704 | $708.06 | 19.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 60 | $2,317 | $645.57 | 27.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 31 | 19,600 | $161,700 | $95,168 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 262 | $91,869 | $19,332 | 21.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 28 | 68 | $28,560 | $6,826 | 23.9% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 15 | 50 | $18,636 | $6,743 | 36.2% |
| 96136 | Psychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes | Office | 2021 | 82 | 183 | $16,842 | $4,013 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 19 | $9,348 | $2,124 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 43 | $10,618 | $1,514 | 14.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 35 | $1,348 | $360.31 | 26.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 33 | 22,500 | $185,625 | $109,047 | 58.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 265 | $58,003 | $16,830 | 29.0% |
About Dr. Alan Finkel, MD
Dr. Alan Finkel, MD is a Neurology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114098530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Finkel, MD has received a total of $405,703 in payments from pharmaceutical and medical device companies, with $11,555 received in 2024. These payments were reported across 1,381 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($265,000).
As a Medicare-enrolled provider, Finkel has provided services to 1,287 Medicare beneficiaries, totaling 80,770 services with total Medicare billing of $546,259. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Durham, NC
- Active Since 11/10/2006
- Last Updated 03/28/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1114098530
Products in Payments
- Aimovig (Biological) $150,397
- BOTOX (Biological) $70,454
- UBRELVY (Drug) $51,217
- REYVOW (Drug) $29,150
- BOTOX (Drug) $18,634
- NURTEC ODT (Drug) $14,268
- Dysport (Drug) $9,254
- AIMOVIG (Biological) $6,648
- BOTOX - MIGRAINE (Drug) $5,288
- Zembrace (Drug) $1,772
- AJOVY (Biological) $1,009
- AMG334A_AIMOVIG_NEUROSCIENCE (Biological) $1,000
- QULIPTA (Drug) $910.74
- VYEPTI (Biological) $767.22
- EMGALITY (Drug) $715.00
- Trudhesa (Drug) $499.75
- NUEDEXTA (Drug) $468.93
- BOTOX CHRONIC MIGRAINE (Drug) $434.79
- TROKENDI XR (Drug) $433.61
- AJOVY (Drug) $382.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Durham
Mark Skeen, M.d, M.D
Neurology — Payments: $770,195
Dr. Kevin Kahn, Md, MD
Neurology — Payments: $662,344
Natalia Gonzalez, Md, MD
Neurology — Payments: $219,812
Dr. Anne Calhoun, Md, MD
Neurology — Payments: $203,020
Dr. Jeffrey Guptill, M.d, M.D
Neurology — Payments: $191,526
Dr. Aatif Husain, M.d, M.D
Neurology — Payments: $185,344